Picking Up the Pieces After Hwang
By Gretchen Vogel,
Science
| 04. 28. 2006
A year ago, it seemed so easy. In May 2005, Woo Suk Hwang and his colleagues told the world that they could make embryonic stem (ES) cells from cloned human embryos with an efficiency that astounded--and thrilled--their colleagues. In roughly one out of every 12 tries, the South Korean team reported, they could produce ES cell lines that were a genetic match to patients. Scientists hoped to use such cells to probe the genetic triggers of diseases such as diabetes and amyotrophic lateral sclerosis (ALS). Some dreamed of using them as the raw material for developing new tissues and cells that could treat previously incurable maladies.
A few months ago, those claims famously unraveled. It is now clear that Hwang's team does not have any ES cell lines created from patients. It is also clear that the group didn't fail for lack of trying: The team apparently used more than 2200 donated human oocytes in their experiments--more than five times the number they claimed in their papers (Science, 10 February, p. 754). The meltdown dashed the hopes of researchers and...
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...